Sitagliptin Vildagliptin And Saxagliptin Dipeptidyl Peptidase

close
PDF
DOC
PPT
Synthesis of (S)-1-(2-chloroacetyl)pyrrolidine-2 ...

Synthesis of (S)-1-(2-chloroacetyl)pyrrolidine-2 ...

Beilstein Journal of Organic Chemistry 2008, 4, No. 20. Page 3 of (page number not for citation purposes) 5 Scheme 3: Preparation of Vildagliptin (2).
Fri, 17 Oct 2014 16:47:00 GMT
RxFiles Q&A Summary Rene Breault BScPharm, PharmD ...

RxFiles Q&A Summary Rene Breault BScPharm, PharmD ...

RxFiles: Q&A Summary www.RxFiles.ca - Nov, 2008 Rene Breault BScPharm, PharmD Candidate; L. Regier BSP BA, B. Jensen BSP Sitagliptin (JANUVIA®)
Sun, 19 Oct 2014 12:41:00 GMT
Saxagliptin for the treatment of type 2 diabetes mellitus ...

Saxagliptin for the treatment of type 2 diabetes mellitus ...

REVIEW Open Access Saxagliptin for the treatment of type 2 diabetes mellitus: assessing cardiovascular data Michael E Cobble1* and Robert Frederich2
Sun, 19 Oct 2014 06:36:00 GMT
A New Therapy of Type 2 Diabetes: DPP-4 Inhibitors

A New Therapy of Type 2 Diabetes: DPP-4 Inhibitors

1 A New Therapy of Type 2 Diabetes: DPP-4 Inhibitors Tatjana Ábel National Health Center Hungary 1. Introduction Type 2 diabetes is a progressive disease which is ...
Tue, 21 Oct 2014 07:02:00 GMT
Stellungnahme der Deutschen Diabetes Gesellschaft (DDG) zu ...

Stellungnahme der Deutschen Diabetes Gesellschaft (DDG) zu ...

kritische und fachübergreifende Stellungnahme zusammen mit der Deutschen Gesellschaft für Innere Medizin (DGIM), der Deutschen Gesellschaft für Kardiologie (DGK ...
Tue, 21 Oct 2014 07:59:00 GMT
Comparison of efficacy between incretin-based therapies ...

Comparison of efficacy between incretin-based therapies ...

comparative trials analyzing efficacy, tolerability and safety profiles between the agents from these two classes. Physiology of incretins The classic ‘incretin ...
Sun, 19 Oct 2014 13:45:00 GMT
Launch Excellence in the Diabetes Market - IMS Health

Launch Excellence in the Diabetes Market - IMS Health

IMS HEALTH |LAUNCH EXCELLENCE IN THE DIABETES MARKET 2 WHITE PAPER |DIABETES LAUNCH EXCELLENCE Growth in the market for Type ...
Sat, 18 Oct 2014 17:43:00 GMT
Australian Public Assessment Report for Linagliptin

Australian Public Assessment Report for Linagliptin

Australian Public Assessment Report for Linagliptin Proprietary Product Name: Trajenta Sponsor: Boehringer Ingleheim (Australia) Pty Ltd December 2011
Sat, 18 Oct 2014 03:31:00 GMT
CHMP ASSESSMENT REPORT FOR Onglyza - European Medicines Agency

CHMP ASSESSMENT REPORT FOR Onglyza - European Medicines Agency

Page 5 of 57 2 SCIENTIFIC DISCUSSION 2.1 Introduction Type 2 Diabetes Mellitus (T2DM) is a common chronic metabolic disorder, which can lead to
Tue, 21 Oct 2014 06:05:00 GMT
Pancreatic Safety of Incretin-Based Drugs — FDA and EMA ...

Pancreatic Safety of Incretin-Based Drugs — FDA and EMA ...

n engl j med 370;9 nejm.org27, 2014february PERSPECTIVE 795 Pancreatic Safety of Incretin-Based Drugs efficacy in improving glycemic control. The benefit ...
Sun, 12 Oct 2014 07:41:00 GMT